Article info
PDFClinical science
Randomised assessor-masked trial evaluating topical manuka honey (Optimel) in treatment of meibomian gland dysfunction
- Correspondence to Professor Alvin Lerrmann Young, Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong; dr.a.l.young{at}gmail.com
Citation
Randomised assessor-masked trial evaluating topical manuka honey (Optimel) in treatment of meibomian gland dysfunction
Publication history
- Received July 16, 2020
- Revised December 3, 2020
- Accepted December 24, 2020
- First published January 8, 2021.
Online issue publication
November 15, 2022
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.